Reich, K, K Papp, A Blauvelt, R Langley, A Armstrong, RB Warren, K Gordon, JF Merola, C Madden, M Wang, V Vanvoorden, and M Lebwohl. “Efficacy and Safety of Bimekizumab in Patients With Moderate to Severe Plaque Psoriasis: Results from BE VIVID, a 52-Week Phase 3, Randomized, Double-Blinded, Ustekinumab- and Placebo-Controlled Study”. SKIN The Journal of Cutaneous Medicine 4, no. 6 (October 27, 2020): s82. Accessed January 27, 2021. https://jofskin.org/index.php/skin/article/view/1115.